Piperonyl butoxide reduces salicylate-induced nephrotoxicity and covalent binding in male rats.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001806:Blood Urea Nitrogen; D003600:Cytosol / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008297:Male; D008861:Microsomes / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D010882:Piperonyl Butoxide / Q000494:pharmacology*; D011485:Protein Binding; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012459:Salicylates / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000633:toxicity*; D020156:Salicylic Acid
D011506:Proteins; D012459:Salicylates; D000255:Adenosine Triphosphate; D000410:Alanine Transaminase; D010882:Piperonyl Butoxide; D020156:Salicylic Acid